0HTC trade ideas
4x Top vs. H&SCan that be true? Will we see a longterm breakout? Or will we see a 4x-Top? Trigger for both szeanrios is the neckline of the huge H&S - the present tradingmark!
Strong Buy recommendation on CARA, just not at this priceI did a write-up on Seeking Alpha on CARA breaking down where the company will be in the future (about 6 - 9 months). I am adding this stock into my portfolio. However, I am expecting the price to drop somewhat and am looking to add in positions as the price moves lower. The more CARA falls, the more I will add in.
Cara is Up and will continue to Go Up!Cara is one of many unreliable weed stocks that many follow but the good news for you is that it is on a uproar! Cara has been down for the last couple weeks but it has made its way back to +0>13% in the last couple days. Like many weed stocks they fluctuate because of the shareholders within the stock are untrained and new to the stock market. This is where you can gain percentage and capital on. By watching the moves of the stock holders you can easily predict where the stock will drop. The only risk in tis is being on top of your buy and sell because the stock holders scare easily. If one jumps they all follow but being the ones who jump at about 25% you can gain the upper hand. for the first 25% of stockholders who jump there will still be people buying into the stock but i have found as soon as you roll over the quarter mark buying stops and everyone scares off. so having said this this you can pinpoint the rough placement of where the drop will be and after you gains are finalized you can buy back in when it has hit rock bottom.
-Jon Matthews
$CARA it was long coming Most likely it will be a huge leap over 20 , I have long position from 14.35
With confirmation candle on #chart and volume
Cara Therapeutics (CARA): a bullish outlookCara Therapeutics announced positive statistically significant results in a phase 2/3 trial for its drug I.V. CR845 which goal is to reduce pain caused by abdominal surgeries. Cara Therapeutics is a small-cap stock, so getting the drug approved will likely have a significant impact on the stock price.
The company is considered highly speculative at this point, but it has demonstrated sufficient progress so investors with a high-risk appetite are keeping a close eye on it.
Cara has a promising pipeline of pain and itch relief drugs that have a large market opportunity if they can gain FDA approval. The company is also working on non-opioid pain relief drugs that have fewer side effects than post-op opioid derived pain drugs currently on the market.
www.finstead.com
CARA: One of the best looking inv H&SI am way too excited for this name. Short term 23-24 but this one is a keeper. No questions about this. Freebies to my followers.
CARA working on C&HLong abused CARA is prepping up. If any marginal good news comes out of the company I expect CARA to be a big winner in 2018.
form the strong trend support in the new low point
now: 12.43
buy: 12.22
stop profit: 12.71
stop loss: 12.04
$CARA una inversion para fumarsela..Compra zona de 11.50-12.50
Stop: 11
Target: Cierre de Gap zona de $25
CARA - Key Support breakdown short with weak fundamentalCARA had a very bad report on one of their drug & for that it is down big time after the market hours & came down to key support label. Now if it bounce back from here $21-22 area would a very good shorting point or break below the support. Hopefully it will be a exciting trade opportunity.
* Trade Criteria *
Date First Found- June 29, 2017
Pattern/Why- Key Support breakdown short with weak fundamental condition
Entry Target Criteria- Pull back to $20.90 area or Break of support around $17
Exit Target Criteria- Momentum
Stop Loss Criteria- N/A
Please check back for Trade updates. (Note: Trade update is little delayed here.)
Be Careful w/ trading CARAThe huge increase in volume during consolidation (even though it broke out further on the upside) has me leaning towards a cautious side. I have seen multiple stocks fail after breaking out!!!
Bullish wedge triggered - is this the end of the consolidation?The EMA 90 (38,2 fibo) was bought, the RSI is confirming that Szenario and made a Kind of buying Signal. On its way up to the March-Top are based several resistances, the fibo Levels.
Trading below 14$ would destroy the weak bullish Sentiment
CARAPrice has pulled back recently to demand level. Should resume uptrend from this level. Good risk/reward at this level
Entry: $16.90
Stop Loss: $16.39
Target 1: $18.50
Target 2: $22
